Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial

MLA

Olga Smirnova, et al. “Efficacy and Safety of Luseogliflozin in Caucasian Patients with Type 2 Diabetes: Results from a Phase III, Randomized, Placebo-Controlled, Clinical Trial.” BMJ Open Diabetes Research & Care, vol. 11, no. 3, May 2023. EBSCOhost, https://doi.org/10.1136/bmjdrc-2022-003290.

APA

Olga Smirnova, Olga Ershova, Marina Shestakova, Boris Kvasnikov, Ekaterina Erina, Elena Isachenko, Alexander Andreev, Diana Alpenidze, Alexander Ametov, Olga Demicheva, Irina Dvoryashina, Polina Ermakova, Elena Grineva, Yuriy Khalimov, Ludmila Kvitkova, Anatoliy Kuzin, Olga Lantseva, Nina Leonova, Tatiana Lysenko, … Larisa Zhukova. (2023). Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial. BMJ Open Diabetes Research & Care, 11(3). https://doi.org/10.1136/bmjdrc-2022-003290

Chicago

Olga Smirnova, Olga Ershova, Marina Shestakova, Boris Kvasnikov, Ekaterina Erina, Elena Isachenko, Alexander Andreev, et al. 2023. “Efficacy and Safety of Luseogliflozin in Caucasian Patients with Type 2 Diabetes: Results from a Phase III, Randomized, Placebo-Controlled, Clinical Trial.” BMJ Open Diabetes Research & Care 11 (3). doi:10.1136/bmjdrc-2022-003290.